Rule 2.10
09 September 2003 - 4:14PM
UK Regulatory
RNS Number:5609P
PPL Therapeutics PLC
09 September 2003
Date: Immediate, Tuesday 9 September 2003
Contact: Geoff Cook, Chief Executive Officer
Lindsay Dunsmuir, Chief Financial Officer
PPL Therapeutics plc Telephone: 0131 440 477
Alistair Mackinnon-Musson
Philip Dennis
Hudson Sandler Telephone: 020 7796 4133
Email: ppl@hspr.co.uk
PPL Therapeutics plc ("PPL")
In accordance with Rule 2.10 of The City Code on Takeovers and Mergers, PPL
Therapeutics announces that it has 118,582,994 ordinary shares in issue of 1
pence each.
The International Securities Identification Number for PPL Therapeutics ordinary
shares is GB0006657448.
- Ends -
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEALNNEFEDEFE